NCT00005095View on ClinicalTrials.gov

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

RecruitingOBSERVATIONAL
Enrollment

6,000

Participants

Timeline

Start Date

March 31, 2000

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2040

Conditions
Cervical CancerEndometrial CancerFallopian Tube CancerHereditary Breast/Ovarian Cancer (brca1, brca2)Ovarian CancerSarcomaUterine LeiomyomataVaginal CancerVulvar Cancer
Interventions
OTHER

Ca-125

Subject's blood collected at their follow-up blood draw will be assessed for biomarkers that could lead to a panel for detecting early stage ovarian cancer.

OTHER

screening questionnaire administration

Questionnaires designed to assess quality of life for women at increased risk of ovarian cancer will be administered to the subjects. Clinical data will also be collected.

PROCEDURE

Surgery

Subjects will be assessed for high risk factors.

Trial Locations (1)

60611-3013

RECRUITING

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER